|
⚲
|
| Keyboard |
| Kayitalire Louis
✚
|
|
|---|---|
| CIK # | 0001831519 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001831519] | |
| 4 | [0001831519] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kayitalire Louis | |
| F-star Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
F-star Therapeutics Inc FSTX
Common Stock
|
2023-03-08 | Tender | 29,236 | $7.12 | 208,160 |
|
F-star Therapeutics Inc FSTX
Common Stock
|
2023-03-08 | Disposed to issuer | 25,019 | $7.12 | 178,135 |
|
F-star Therapeutics Inc FSTX
Stock Option (right to buy) · derivative
|
2023-03-08 | Disposed to issuer | 12,880 | ||
|
F-star Therapeutics Inc FSTX
Stock Option (right to buy) · derivative
|
2023-03-08 | Disposed to issuer | 53,634 | ||
|
F-star Therapeutics Inc FSTX
Stock Option (right to buy) · derivative
|
2023-03-08 | Disposed to issuer | 27,289 | ||
|
F-star Therapeutics Inc FSTX
Stock Option (right to buy) · derivative
|
2023-03-08 | Disposed to issuer | 35,719 | ||
|
F-star Therapeutics Inc FSTX
Stock Option (right to buy) · derivative
|
2022-03-31 | Grant | 35,719 | $0.00 | |
|
F-star Therapeutics Inc FSTX
Stock Option (right to buy) · derivative
|
2022-01-09 | Grant | 53,634 | $0.00 | |
|
F-star Therapeutics Inc FSTX
Common Stock
|
2021-11-02 | Sell | 39 | $6.81 | 266 |
|
F-star Therapeutics Inc FSTX
Common Stock
|
2021-11-02 | Sell | 25 | $6.85 | 171 |
|
F-star Therapeutics Inc FSTX
Common Stock
|
2021-10-04 | Sell | 64 | $7.23 | 463 |
|
F-star Therapeutics Inc FSTX
Common Stock
|
2021-07-02 | Sell | 1,054 | $8.43 | 8,885 |
|
F-star Therapeutics Inc FSTX
Stock Option (right to buy) · derivative
|
2021-03-09 | Grant | 12,880 | $0.00 | |
|
F-star Therapeutics Inc FSTX
Common Stock
|
2021-02-01 | Grant | 29,000 | $0.00 | |
|
F-star Therapeutics Inc FSTX
Stock Option (right to buy) · derivative
|
2020-11-20 | Grant | 27,289 | $0.00 | |
|
F-star Therapeutics Inc FSTX
Restricted Stock Units · derivative
|
2020-11-20 | Grant | 26,437 | $0.00 |